Membrane Steroid Transporter Screening for Selective Modulation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for regulating steroid hormone effects often result in unwanted side effects due to the administration of synthetic or natural steroid hormones or antagonists, necessitating alternative approaches to control steroid hormone signaling.
Innovation Solution
A method is developed to identify compounds that modulate the transport of steroid hormones across cell membranes by steroid hormone transporters, using a comparative screening approach between cells with and without the transporter gene, and assessing transcriptional activity through luciferase reporter assays.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If steroid hormones or steroid hormone antagonists are administered to control steroid hormone effects, then the ability to regulate steroid hormone signaling is improved, but unwanted side effects increase
Solution Approach 1:
The patent introduces membrane steroid transporters as intermediary proteins that mediate the uptake of steroid hormones into cells. By targeting these transporters with selective compounds, the invention enables control of steroid hormone effects through an intermediate mechanism rather than direct hormone administration, thereby reducing side effects while maintaining regulatory capability
Solution Approach 2:
The invention employs selective compounds that target specific membrane steroid transporters with high specificity. This local quality approach ensures that only the intended transporter-hormone interaction is modulated, leaving other physiological processes unaffected, thus reducing unwanted side effects while maintaining reliable regulation of steroid hormone signaling
2Measurement precision
If a screening method uses cells expressing steroid hormone transporter genes to identify modulating compounds, then the precision of compound identification is improved, but the complexity of the screening system increases
Solution Approach 1:
The screening method segments the evaluation process into distinct components: (1) cells expressing specific steroid hormone transporter genes, (2) candidate compound treatment, and (3) measurement of steroid hormone transport or nuclear receptor transcriptional activity. This segmentation allows for precise identification of compounds that specifically modulate transporter function without requiring complex whole-organism models
Solution Approach 2:
The patent uses luciferase reporter assays as an intermediary measurement system to detect nuclear receptor transcriptional activity. This intermediary approach translates complex biological responses into quantifiable luminescence signals, improving measurement precision while maintaining manageable screening system complexity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method allows for the identification of compounds that can selectively influence steroid hormone transport and transcriptional activity, potentially reducing side effects and providing targeted hormone therapy options.
Implementation Method 1
Steroid hormones are lipophilic, and are generally believed to enter cells by simple diffusion across the lipid bilayer
Implementation Method 2
determining the transcriptional activity of the steroid hormone nuclear receptor in the initial cell and the comparative cell
Data Source
AI summary
Described herein are methods of identifying compounds that can modulate the transport of a steroid hormone across a phospholipid membrane. Also described herein are methods of identifying compounds that can affect the transcriptional activity of a steroid hormone nuclear receptor.